GlassScriptPhysician profile
Alexandra L Mathern
NPI 1598149171
$1,464.24
in general payments reported to CMS, 2019-2025
19 companies · $511 in 2025
The $511 reported for 2025 was more than what 80% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.84 · 2021: $160 · 2022: $77.21 · 2023: $288 · 2024: $397 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.06 | 2020-2025 | |
| Astellas Pharma US INC | $323.83 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $230.74 | 2023-2025 | Gemtesa, Myfembree |
| Pfizer INC. | $110.03 | 2023-2025 | |
| Biogen, INC. | $86.17 | 2024-2025 | Zurzuvae |
| Organon LLC | $55.52 | 2024-2025 | Nexplanon |
| Amgen INC. | $47.22 | 2021-2023 | Prolia, Evenity |
| Exeltis, USA INC. | $44.76 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $39.83 | 2024-2025 | Myosure Tissue Removal Device, Coolseal Generator |
| Arjo INC. | $28.04 | 2025 | |
| Therapeuticsmd, INC. | $27.62 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $26.50 | 2024 | |
| Channel Medsystems, INC. | $19.63 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.53 | 2023 | Exparel |
| Evofem Biosciences, INC. | $16.96 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $16.61 | 2022 | |
| Becton, Dickinson and Company | $13.94 | 2024 | Bd Onclarity |
| Bayer Healthcare Pharmaceuticals INC. | $13.93 | 2025 | |
| Mayne Pharma Commercial LLC | $12.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Mathern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.